Nivolumab Combined With Daratumumab With or Without Low-dose Cyclophosphamide
Clinical trial NCT03184194 · COMPLETED
Trial details
- NCT number
- NCT03184194
- Sponsor
- Amsterdam UMC, location VUmc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-21
- Primary completion
- 2023-01-25
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.